{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:13:02Z","timestamp":1790374382627,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T00:00:00Z","timestamp":1447459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Health Council of Castilla y Le\u00f3n","award":["GRS265\/A\/08),"],"award-info":[{"award-number":["GRS265\/A\/08),"]}]},{"name":"Health Research Program","award":["PS09\/01382"],"award-info":[{"award-number":["PS09\/01382"]}]},{"name":"R\u00edo Hortega, an ISCIII contract","award":["CM10\/00078"],"award-info":[{"award-number":["CM10\/00078"]}]},{"name":"Juan Rod\u00e9s, an ISCIII contract","award":["JR14\/00025"],"award-info":[{"award-number":["JR14\/00025"]}]},{"name":"Subprograma Juan de la Cierva","award":["JCI-2011-10232"],"award-info":[{"award-number":["JCI-2011-10232"]}]},{"name":"Miguel Servet contract","award":["CP13\/00159"],"award-info":[{"award-number":["CP13\/00159"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00277-015-2552-3","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T01:06:06Z","timestamp":1447463166000},"page":"253-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma"],"prefix":"10.1007","volume":"95","author":[{"given":"Elena","family":"Sebasti\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Alcoceba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mart\u00edn-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Sanchez-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Balanzategui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonz\u00e1lez-Barca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Pardal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"Clot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma C.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eugenia","family":"Sarasquete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Chill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Prieto-Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Dolores","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Salaverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,14]]},"reference":[{"key":"2552_CR1","unstructured":"Swerdlow SH, Cancer IA for R on (2008) WHO classification of tumours of haematopoietic and lymphoid tissues: vol. 2: International Agency for Research on Cancer, Edici\u00f3n: 4th ed., 2008. WHO"},{"key":"2552_CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503\u2013511. doi: 10.1038\/35000501","journal-title":"Nature"},{"key":"2552_CR3","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS et al (2008) Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359:2313\u20132323. doi: 10.1056\/NEJMoa0802885","journal-title":"N Engl J Med"},{"key":"2552_CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275\u2013282. doi: 10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"key":"2552_CR5","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","volume":"15","author":"WWL Choi","year":"2009","unstructured":"Choi WWL, Weisenburger DD, Greiner TC et al (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res Off J Am Assoc Cancer Res 15:5494\u20135502. doi: 10.1158\/1078-0432.CCR-09-0113","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2552_CR6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","volume":"29","author":"PN Meyer","year":"2011","unstructured":"Meyer PN, Fu K, Greiner TC et al (2011) Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol Off J Am Soc Clin Oncol 29:200\u2013207. doi: 10.1200\/JCO.2010.30.0368","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2552_CR7","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","volume":"26","author":"C Visco","year":"2012","unstructured":"Visco C, Li Y, Xu-Monette ZY et al (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 26:2103\u20132113. doi: 10.1038\/leu.2012.83","journal-title":"Leukemia"},{"key":"2552_CR8","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2010-12-322362","volume":"117","author":"G Guti\u00e9rrez-Garc\u00eda","year":"2011","unstructured":"Guti\u00e9rrez-Garc\u00eda G, Cardesa-Salzmann T, Climent F et al (2011) Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood 117:4836\u20134843. doi: 10.1182\/blood-2010-12-322362","journal-title":"Blood"},{"key":"2552_CR9","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2006-09-047068","volume":"109","author":"H Nyman","year":"2007","unstructured":"Nyman H, Adde M, Karjalainen-Lindsberg M-L et al (2007) Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood 109:4930\u20134935. doi: 10.1182\/blood-2006-09-047068","journal-title":"Blood"},{"key":"2552_CR10","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2007.15.9277","volume":"26","author":"K Fu","year":"2008","unstructured":"Fu K, Weisenburger DD, Choi WWL et al (2008) Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. J Clin Oncol Off J Am Soc Clin Oncol 26:4587\u20134594. doi: 10.1200\/JCO.2007.15.9277","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2552_CR11","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","volume":"114","author":"KJ Savage","year":"2009","unstructured":"Savage KJ, Johnson NA, Ben-Neriah S et al (2009) MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 114:3533\u20133537. doi: 10.1182\/blood-2009-05-220095","journal-title":"Blood"},{"key":"2552_CR12","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","volume":"28","author":"S Barrans","year":"2010","unstructured":"Barrans S, Crouch S, Smith A et al (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol Off J Am Soc Clin Oncol 28:3360\u20133365. doi: 10.1200\/JCO.2009.26.3947","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2552_CR13","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1002\/cncr.27396","volume":"118","author":"N Akyurek","year":"2012","unstructured":"Akyurek N, Uner A, Benekli M, Barista I (2012) Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab. Cancer 118:4173\u20134183. doi: 10.1002\/cncr.27396","journal-title":"Cancer"},{"key":"2552_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF02983534","volume":"79","author":"C Ueda","year":"2004","unstructured":"Ueda C, Nishikori M, Kitawaki T et al (2004) Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. Int J Hematol 79:52\u201354","journal-title":"Int J Hematol"},{"key":"2552_CR15","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H et al (2006) A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419\u20132430. doi: 10.1056\/NEJMoa055351","journal-title":"N Engl J Med"},{"key":"2552_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A et al (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471:189\u2013195. doi: 10.1038\/nature09730","journal-title":"Nature"},{"key":"2552_CR17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Trifonov V, Fabbri G et al (2011) Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43:830\u2013837. doi: 10.1038\/ng.892","journal-title":"Nat Genet"},{"key":"2552_CR18","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","volume":"109","author":"JG Lohr","year":"2012","unstructured":"Lohr JG, Stojanov P, Lawrence MS et al (2012) Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 109:3879\u20133884. doi: 10.1073\/pnas.1121343109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2552_CR19","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","volume":"122","author":"RD Morin","year":"2013","unstructured":"Morin RD, Mungall K, Pleasance E et al (2013) Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood 122:1256\u20131265. doi: 10.1182\/blood-2013-02-483727","journal-title":"Blood"},{"key":"2552_CR20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2005.02.4786","volume":"24","author":"IS Lossos","year":"2006","unstructured":"Lossos IS, Morgensztern D (2006) Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol Off J Am Soc Clin Oncol 24:995\u20131007. doi: 10.1200\/JCO.2005.02.4786","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2552_CR21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM199708213370804","volume":"337","author":"A Ichikawa","year":"1997","unstructured":"Ichikawa A, Kinoshita T, Watanabe T et al (1997) Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 337:529\u2013534. doi: 10.1056\/NEJM199708213370804","journal-title":"N Engl J Med"},{"key":"2552_CR22","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2007-02-072082","volume":"110","author":"KH Young","year":"2007","unstructured":"Young KH, Weisenburger DD, Dave BJ et al (2007) Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. Blood 110:4396\u20134405. doi: 10.1182\/blood-2007-02-072082","journal-title":"Blood"},{"key":"2552_CR23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.leukres.2008.06.022","volume":"33","author":"N Zainuddin","year":"2009","unstructured":"Zainuddin N, Berglund M, Wanders A et al (2009) TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype. Leuk Res 33:60\u201366. doi: 10.1016\/j.leukres.2008.06.022","journal-title":"Leuk Res"},{"key":"2552_CR24","first-page":"107","volume":"14","author":"M Osada","year":"1999","unstructured":"Osada M, Ishioka C, Ichinohasama R et al (1999) Influence of p53 mutation on pathological grade, but not prognosis of non-Hodgkin\u2019s lymphoma. Anticancer Drug Des 14:107\u2013114","journal-title":"Anticancer Drug Des"},{"key":"2552_CR25","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.V99.4.1136","volume":"99","author":"SL Barrans","year":"2002","unstructured":"Barrans SL, Carter I, Owen RG et al (2002) Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 99:1136\u20131143","journal-title":"Blood"},{"key":"2552_CR26","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","volume":"27","author":"C Jim\u00e9nez","year":"2013","unstructured":"Jim\u00e9nez C, Sebasti\u00e1n E, Chill\u00f3n MC et al (2013) MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstr\u00f6m\u2019s macroglobulinemia. Leukemia 27:1722\u20131728. doi: 10.1038\/leu.2013.62","journal-title":"Leukemia"},{"key":"2552_CR27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo VN, Young RM, Schmitz R et al (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470:115\u2013119. doi: 10.1038\/nature09671","journal-title":"Nature"},{"key":"2552_CR28","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","volume":"110","author":"J Zhang","year":"2013","unstructured":"Zhang J, Grubor V, Love CL et al (2013) Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A 110:1398\u20131403. doi: 10.1073\/pnas.1205299110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2552_CR29","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","volume":"106","author":"S Bea","year":"2005","unstructured":"Bea S, Zettl A, Wright G et al (2005) Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 106:3183\u20133190. doi: 10.1182\/blood-2005-04-1399","journal-title":"Blood"},{"key":"2552_CR30","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/ijc.29072","volume":"136","author":"R Scholtysik","year":"2015","unstructured":"Scholtysik R, Kreuz M, Hummel M et al (2015) Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis. Int J Cancer 136:1033\u20131042. doi: 10.1002\/ijc.29072","journal-title":"Int J Cancer"},{"key":"2552_CR31","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","volume":"362","author":"G Lenz","year":"2010","unstructured":"Lenz G, Staudt LM (2010) Aggressive lymphomas. N Engl J Med 362:1417\u20131429. doi: 10.1056\/NEJMra0807082","journal-title":"N Engl J Med"},{"key":"2552_CR32","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1182\/blood-2009-11-203182","volume":"115","author":"S Heinrichs","year":"2010","unstructured":"Heinrichs S, Li C, Look AT (2010) SNP array analysis in hematologic malignancies: avoiding false discoveries. Blood 115:4157\u20134161. doi: 10.1182\/blood-2009-11-203182","journal-title":"Blood"},{"key":"2552_CR33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.2270","volume":"44","author":"KB Jacobs","year":"2012","unstructured":"Jacobs KB, Yeager M, Zhou W et al (2012) Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 44:651\u2013658. doi: 10.1038\/ng.2270","journal-title":"Nat Genet"},{"key":"2552_CR34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.2010.08326.x","volume":"151","author":"M Scandurra","year":"2010","unstructured":"Scandurra M, Mian M, Greiner TC et al (2010) Genomic lesions associated with a different clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP-21. Br J Haematol 151:221\u2013231. doi: 10.1111\/j.1365-2141.2010.08326.x","journal-title":"Br J Haematol"},{"key":"2552_CR35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/gcc.20856","volume":"50","author":"MR Green","year":"2011","unstructured":"Green MR, Aya-Bonilla C, Gandhi MK et al (2011) Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin\u2019s lymphoma. Genes Chromosomes Cancer 50:313\u2013326. doi: 10.1002\/gcc.20856","journal-title":"Genes Chromosomes Cancer"},{"key":"2552_CR36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ccr.2012.07.014","volume":"22","author":"S Monti","year":"2012","unstructured":"Monti S, Chapuy B, Takeyama K et al (2012) Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell 22:359\u2013372. doi: 10.1016\/j.ccr.2012.07.014","journal-title":"Cancer Cell"},{"key":"2552_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1755-8794-2-8","volume":"2","author":"Y Wang","year":"2009","unstructured":"Wang Y, Carlton VEH, Karlin-Neumann G et al (2009) High quality copy number and genotype data from FFPE samples using molecular inversion probe (MIP) microarrays. BMC Med Genomics 2:8. doi: 10.1186\/1755-8794-2-8","journal-title":"BMC Med Genomics"},{"key":"2552_CR38","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM Dongen van","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Br\u00fcggemann M et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257\u20132317. doi: 10.1038\/sj.leu.2403202","journal-title":"Leukemia"},{"key":"2552_CR39","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1200\/JCO.2010.32.0838","volume":"29","author":"D Gonzalez","year":"2011","unstructured":"Gonzalez D, Martinez P, Wade R et al (2011) Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. J Clin Oncol Off J Am Soc Clin Oncol 29:2223\u20132229. doi: 10.1200\/JCO.2010.32.0838","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2552_CR40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAI.0000000000000020","volume":"22","author":"C Jim\u00e9nez","year":"2014","unstructured":"Jim\u00e9nez C, Chill\u00f3n MDC, Balanzategui A et al (2014) Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction. Appl Immunohistochem Mol Morphol AIMM Off Publ Soc Appl Immunohistochem 22:768\u2013773. doi: 10.1097\/PAI.0000000000000020","journal-title":"Appl Immunohistochem Mol Morphol AIMM Off Publ Soc Appl Immunohistochem"},{"key":"2552_CR41","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ajpath.2012.07.028","volume":"181","author":"E Sebasti\u00e1n","year":"2012","unstructured":"Sebasti\u00e1n E, Alcoceba M, Balanzategui A et al (2012) Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype. Am J Pathol 181:1879\u20131888. doi: 10.1016\/j.ajpath.2012.07.028","journal-title":"Am J Pathol"},{"key":"2552_CR42","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2013-02-483420","volume":"122","author":"M Alcoceba","year":"2013","unstructured":"Alcoceba M, Sebasti\u00e1n E, Mar\u00edn L et al (2013) HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma. Blood 122:1448\u20131454. doi: 10.1182\/blood-2013-02-483420","journal-title":"Blood"},{"key":"2552_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-9-1","volume":"9","author":"J Sidney","year":"2008","unstructured":"Sidney J, Peters B, Frahm N et al (2008) HLA class I supertypes: a revised and updated classification. BMC Immunol 9:1. doi: 10.1186\/1471-2172-9-1","journal-title":"BMC Immunol"},{"key":"2552_CR44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","volume":"63","author":"J Greenbaum","year":"2011","unstructured":"Greenbaum J, Sidney J, Chung J et al (2011) Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63:325\u2013335. doi: 10.1007\/s00251-011-0513-0","journal-title":"Immunogenetics"},{"key":"2552_CR45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","volume":"148","author":"T Rausch","year":"2012","unstructured":"Rausch T, Jones DTW, Zapatka M et al (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148:59\u201371. doi: 10.1016\/j.cell.2011.12.013","journal-title":"Cell"},{"key":"2552_CR46","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1182\/blood-2012-04-423517","volume":"120","author":"J Edelmann","year":"2012","unstructured":"Edelmann J, Holzmann K, Miller F et al (2012) High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 120:4783\u20134794. doi: 10.1182\/blood-2012-04-423517","journal-title":"Blood"},{"key":"2552_CR47","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1101\/gad.229559.113","volume":"27","author":"C-Z Zhang","year":"2013","unstructured":"Zhang C-Z, Leibowitz ML, Pellman D (2013) Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev 27:2513\u20132530. doi: 10.1101\/gad.229559.113","journal-title":"Genes Dev"},{"key":"2552_CR48","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria I, Martin-Guerrero I, Wagener R et al (2014) A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood 123:1187\u20131198. doi: 10.1182\/blood-2013-06-507996","journal-title":"Blood"},{"key":"2552_CR49","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","volume":"105","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright GW, Emre NCT et al (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A 105:13520\u201313525. doi: 10.1073\/pnas.0804295105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2552_CR50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cancergen.2010.12.010","volume":"204","author":"F Kreisel","year":"2011","unstructured":"Kreisel F, Kulkarni S, Kerns RT et al (2011) High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy. Cancer Genet 204:129\u2013137. doi: 10.1016\/j.cancergen.2010.12.010","journal-title":"Cancer Genet"},{"key":"2552_CR51","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1200\/JCO.2004.11.025","volume":"22","author":"S Be\u00e0","year":"2004","unstructured":"Be\u00e0 S, Colomo L, L\u00f3pez-Guillermo A et al (2004) Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol Off J Am Soc Clin Oncol 22:3498\u20133506. doi: 10.1200\/JCO.2004.11.025","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2552_CR52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijc.10824","volume":"103","author":"ES Jordanova","year":"2003","unstructured":"Jordanova ES, Riemersma SA, Philippo K et al (2003) Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system. Int J Cancer 103:393\u2013398. doi: 10.1002\/ijc.10824","journal-title":"Int J Cancer"},{"key":"2552_CR53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.2399","volume":"216","author":"M Booman","year":"2008","unstructured":"Booman M, Szuhai K, Rosenwald A et al (2008) Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways. J Pathol 216:209\u2013217. doi: 10.1002\/path.2399","journal-title":"J Pathol"},{"key":"2552_CR54","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3109\/10428190903308064","volume":"50","author":"LH Sehn","year":"2009","unstructured":"Sehn LH (2009) Early detection of patients with poor risk diffuse large B-cell lymphoma. Leuk Lymphoma 50:1744\u20131747. doi: 10.3109\/10428190903308064","journal-title":"Leuk Lymphoma"},{"key":"2552_CR55","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.3324\/haematol.2014.104976","volume":"99","author":"S Montes-Moreno","year":"2014","unstructured":"Montes-Moreno S, Batlle A, de Villambros\u00eda SG et al (2014) Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis. Haematologica 99:e138\u2013141. doi: 10.3324\/haematol.2014.104976","journal-title":"Haematologica"},{"key":"2552_CR56","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3109\/10428194.2014.981670","volume":"56","author":"M Testoni","year":"2015","unstructured":"Testoni M, Chung EYL, Priebe V, Bertoni F (2015) The transcription factor ETS1 in lymphomas: friend or foe? Leuk Lymphoma 56:1975\u20131980. doi: 10.3109\/10428194.2014.981670","journal-title":"Leuk Lymphoma"},{"key":"2552_CR57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/82712","volume":"1","author":"RM Siegel","year":"2000","unstructured":"Siegel RM, Chan FK, Chun HJ, Lenardo MJ (2000) The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1:469\u2013474. doi: 10.1038\/82712","journal-title":"Nat Immunol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2552-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2552-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:50:03Z","timestamp":1559022603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2552-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,14]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2552-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,14]]}}}